SARS-CoV-2 spike-specific CD4+ and CD8+ T cells induced by prior infection or COVID-19 vaccination provide extensive immune coverage against the Omicron [33,34,35,37] and Delta strains [30]. The gene discussed is CD4; the disease is COVID-19.